• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多能干细胞来源的人类多细胞肝类器官的生成。

Generation of multi-cellular human liver organoids from pluripotent stem cells.

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

出版信息

Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.

DOI:10.1016/bs.mcb.2020.03.009
PMID:32586449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8011941/
Abstract

A growing number of in vitro hepatic models exist to study human genetics, liver biology, disease modeling and drug development and range from 2D hepatocytes to 3D multi-cellular tissues that are derived from human stem cells. However, stem cell-based models generally suffer from batch-, clone- and donor-dependent variability, hindering broader usage in diverse biomedical applications. To circumvent this challenge, we herein describe a reproducible protocol to generate human liver organoids in 20-25 days derived from pluripotent stem cells (PSCs). These organoids are intra-luminally polarized to form canalicular structures and are comprised of mainly hepatic epithelial cells, co-differentiated with stellate-like and hepatic macrophage-like cells that enables hepatic inflammatory disease modeling in vitro. These multi-lineage liver organoids express hepatocyte genes, secrete albumin and have vital metabolic functions. This protocol utilizes PSC derived 3D human liver organoids as a renewable, reproducible and personalized cell source, thus facilitating disease modeling and mechanistic studies with a future goal of developing novel therapeutics against currently intractable diseases.

摘要

越来越多的体外肝脏模型被用于研究人类遗传学、肝脏生物学、疾病建模和药物开发,范围从 2D 肝细胞到源自人类干细胞的 3D 多细胞组织。然而,基于干细胞的模型通常存在批次、克隆和供体依赖性变异性,这阻碍了它们在各种生物医学应用中的广泛使用。为了克服这一挑战,我们在此描述了一种在 20-25 天内从多能干细胞 (PSC) 生成人类肝类器官的可重复协议。这些类器官在腔内向极化形成胆小管结构,并主要由肝细胞组成,与星状细胞和肝巨噬细胞样细胞共分化,从而能够在体外进行肝炎症性疾病建模。这些多能性肝类器官表达肝细胞基因,分泌白蛋白,并具有重要的代谢功能。该方案利用 PSC 衍生的 3D 人类肝类器官作为可再生、可重复和个性化的细胞来源,从而促进疾病建模和机制研究,未来的目标是开发针对目前难以治疗疾病的新型治疗方法。

相似文献

1
Generation of multi-cellular human liver organoids from pluripotent stem cells.多能干细胞来源的人类多细胞肝类器官的生成。
Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.
2
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.扩增型人多能干细胞来源的肝样类器官的生成。
J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.
3
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells.从人类多能干细胞生成肾祖细胞和肾类器官。
Nat Protoc. 2017 Jan;12(1):195-207. doi: 10.1038/nprot.2016.170. Epub 2016 Dec 22.
4
A Scalable Approach for the Generation of Human Pluripotent Stem Cell-Derived Hepatic Organoids with Sensitive Hepatotoxicity Features.一种可扩展的方法,用于生成具有敏感肝毒性特征的人多能干细胞衍生的肝类器官。
Stem Cells Dev. 2017 Oct 15;26(20):1490-1504. doi: 10.1089/scd.2017.0023. Epub 2017 Aug 24.
5
In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.在 3D 可灌注芯片系统中,从人诱导多能干细胞原位分化并生成功能性肝类器官。
Lab Chip. 2018 Dec 7;18(23):3606-3616. doi: 10.1039/c8lc00869h. Epub 2018 Oct 25.
6
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.利用多能干细胞衍生类器官模拟肝脂肪变性。
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
7
Generation of small intestinal organoids for experimental intestinal physiology.用于实验性肠道生理学的小肠类器官的生成。
Methods Cell Biol. 2020;159:143-174. doi: 10.1016/bs.mcb.2020.03.007. Epub 2020 May 4.
8
Engineering human hepato-biliary-pancreatic organoids from pluripotent stem cells.从多能干细胞中工程化人类肝胆胰腺类器官。
Nat Protoc. 2021 Feb;16(2):919-936. doi: 10.1038/s41596-020-00441-w. Epub 2021 Jan 11.
9
Stem cell-derived kidney organoids: engineering the vasculature.干细胞衍生的肾脏类器官:血管工程。
Cell Mol Life Sci. 2020 Jun;77(12):2257-2273. doi: 10.1007/s00018-019-03401-0. Epub 2019 Dec 5.
10
Differentiation of Retinal Organoids from Human Pluripotent Stem Cells.从人类多能干细胞分化视网膜类器官
Curr Protoc Stem Cell Biol. 2019 Sep;50(1):e95. doi: 10.1002/cpsc.95.

引用本文的文献

1
Multi-photon, label-free photoacoustic and optical imaging of NADH in brain cells.脑细胞中烟酰胺腺嘌呤二核苷酸(NADH)的多光子、无标记光声和光学成像。
Light Sci Appl. 2025 Aug 7;14(1):264. doi: 10.1038/s41377-025-01895-x.
2
Organoid-Guided Precision Medicine: From Bench to Bedside.类器官引导的精准医学:从实验室到临床
MedComm (2020). 2025 May 1;6(5):e70195. doi: 10.1002/mco2.70195. eCollection 2025 May.
3
3D tumor cultures for drug resistance and screening development in clinical applications.用于临床应用中耐药性研究和筛选开发的3D肿瘤培养物。

本文引用的文献

1
Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury.人胚胎干细胞衍生的可扩增肝类器官可实现治疗性肝再生以及酒精性肝损伤的病理生理建模。
Cell Res. 2019 Dec;29(12):1009-1026. doi: 10.1038/s41422-019-0242-8. Epub 2019 Oct 18.
2
Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.用于预测药物性肝损伤的器官型和微生理肝脏模型的综合评估
Front Pharmacol. 2019 Sep 24;10:1093. doi: 10.3389/fphar.2019.01093. eCollection 2019.
3
Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling.
Mol Cancer. 2025 Mar 21;24(1):93. doi: 10.1186/s12943-025-02281-2.
4
Hepatobiliary organoid research: the progress and applications.肝胆类器官研究:进展与应用
Front Pharmacol. 2025 Feb 11;16:1473863. doi: 10.3389/fphar.2025.1473863. eCollection 2025.
5
Organoid, organ-on-a-chip and traditional Chinese medicine.类器官、芯片上的器官与传统中药。
Chin Med. 2025 Feb 12;20(1):22. doi: 10.1186/s13020-025-01071-8.
6
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids.利用人多能干细胞衍生的肝类器官构建代谢相关脂肪性肝炎模型。
Hepatol Commun. 2024 Nov 29;8(12). doi: 10.1097/HC9.0000000000000585. eCollection 2024 Dec 1.
7
A High-Throughput Microphysiological Liver Chip System to Model Drug-Induced Liver Injury Using Human Liver Organoids.一种使用人肝类器官模拟药物性肝损伤的高通量微生理肝芯片系统。
Gastro Hep Adv. 2024 Aug 12;3(8):1045-1053. doi: 10.1016/j.gastha.2024.08.004. eCollection 2024.
8
Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.肝脏中miR-149-5p的上调促进小鼠和人肝脏类器官中的脂肪变性、炎症和纤维化发展。
JHEP Rep. 2024 Jun 4;6(9):101126. doi: 10.1016/j.jhepr.2024.101126. eCollection 2024 Sep.
9
Reproducible generation of human liver organoids (HLOs) on a pillar plate platform microarray 3D bioprinting.在柱状板平台微阵列 3D 生物打印技术上可重现地生成人类肝类器官(HLO)。
Lab Chip. 2024 May 14;24(10):2747-2761. doi: 10.1039/d4lc00149d.
10
Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays.用于肝毒性检测的柱形/灌注板中的再生人肝类器官(HLOs)。
bioRxiv. 2024 Nov 3:2024.03.25.586638. doi: 10.1101/2024.03.25.586638.
用于疾病建模的内胚层来源的肝类器官的稳健、长期培养。
Stem Cell Reports. 2019 Oct 8;13(4):627-641. doi: 10.1016/j.stemcr.2019.08.007. Epub 2019 Sep 12.
4
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.扩增型人多能干细胞来源的肝样类器官的生成。
J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.
5
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.利用多能干细胞衍生类器官模拟肝脂肪变性。
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
6
Organoids of liver diseases: From bench to bedside.肝脏疾病类器官:从基础研究到临床应用。
World J Gastroenterol. 2019 Apr 28;25(16):1913-1927. doi: 10.3748/wjg.v25.i16.1913.
7
Generation of hepatobiliary organoids from human induced pluripotent stem cells.从人诱导多能干细胞生成肝胆类器官。
J Hepatol. 2019 Jun;70(6):1145-1158. doi: 10.1016/j.jhep.2018.12.028. Epub 2019 Jan 7.
8
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.巨噬细胞在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159. doi: 10.1038/s41575-018-0082-x.
9
Generation of human antral and fundic gastric organoids from pluripotent stem cells.从多能干细胞生成人类胃窦和胃底类器官。
Nat Protoc. 2019 Jan;14(1):28-50. doi: 10.1038/s41596-018-0080-z.
10
Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.肝脏疾病的体外模型:iPSC 和类器官作为一种新的肝脏疾病建模方法。
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):920-928. doi: 10.1016/j.bbadis.2018.08.038. Epub 2018 Sep 5.